المصدر: MarketBeat
وكالة أنباء
الأسهم
أهمية متوسطة
Novavax Q2 Earnings Call Highlights
Novavax NASDAQ: NVAX reported second-quarter 2026 revenue of $57 million and a net loss of $53 million, while highlighting progress in its Sanofi partnership, expanding use of its Matrix-M adjuvant platform and continued cost reductions.
الرموز ذات الصلة
1
N
NVAX
NVAX
المصدر: MarketBeat
زيارة المصدر